Blurring Strength & Aberrometric Changes Following Corneal Cross-linking (CxL) and CxL Combined With Photorefractive Keratectomy (PRK) in Keratoconus
Condition(s):KeratoconusLast Updated:January 18, 2017Completed
Hide Studies Not Open or Pending
Condition(s):KeratoconusLast Updated:January 18, 2017Completed
Condition(s):Dry Eye; Dry Eye Syndromes; Meibomian Gland DysfunctionLast Updated:June 11, 2020Unknown status
Condition(s):Macular Edema; Branch Retinal Vein OcclusionLast Updated:February 11, 2008Completed
Condition(s):Deep Retinal Capillary Ischemia; Paracentral Acute Middle Maculopathy; Acute Macular NeuroretinopathyLast Updated:January 27, 2020Completed
Condition(s):RetinopathyLast Updated:June 9, 2015Unknown status
Condition(s):Meibomian Gland DysfunctionLast Updated:April 25, 2023Recruiting
Condition(s):Macular Edema; Fibrosis of the RetinaLast Updated:July 8, 2022Terminated
Condition(s):Keratoconus; GlaucomaLast Updated:October 4, 2023Recruiting
Condition(s):Anesthesia, Local; Eyelid DiseasesLast Updated:September 25, 2019Unknown status
Condition(s):Autonomic Nervous System Diseases; Orthostatic Hypotension; Dopamine Beta-Hydroxylase Deficiency; Orthostatic IntoleranceLast Updated:May 12, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.